Among genetically confirmed FTD cases, GRN mutation carriers usually exhibited higher NfL levels and faster rates of increase compared to other genetic subgroups (MAPT, C9orf72) [44,50,51,52,53,54,56,57]. The gene discussed is MAPT; the disease is frontotemporal dementia.